Cambridge, United Kingdom

Daniel Adrian Bygrave

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Cambridge, GB (2023)
  • Essex, GB (2024)

Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Daniel Bygrave in the Field of Biotechnology

Introduction

Daniel Bygrave, an accomplished inventor based in Essex, Great Britain, has made significant strides in biotechnology through his inventive approaches. His commitment to advancing the field is exemplified by his innovative patent that propels our understanding of polynucleotides.

Latest Patents

Daniel Bygrave holds a notable patent titled "Method for producing double stranded polynucleotides based on oligonucleotides with selected and different melting temperatures." This method focuses on identifying a group of single-stranded oligonucleotides for self-assembly into a double-stranded polynucleotide. A unique feature of this invention is that the group consists of overlapping complementary oligonucleotides, with each overlap selected to have a melting temperature (Tm) that significantly differs from that of others in the group. This innovative approach enhances the efficiency and specificity of polynucleotide formation, which has important implications for genetic research and therapy.

Career Highlights

Daniel is currently employed at Evonetix Limited, where he contributes to the company’s pioneering efforts in the field of synthetic biology. His work focuses on developing technologies that facilitate the synthesis of DNA, providing groundbreaking solutions for genetic engineering and related applications.

Collaborations

At Evonetix Limited, Daniel collaborates with talented coworkers such as Joseph Brennan and Sangeeta Aditya. Together, they work on various projects that leverage cutting-edge technologies to enhance DNA synthesis and other related innovations. Their teamwork exemplifies the collaborative spirit that drives progress in the biotechnology sector.

Conclusion

In conclusion, Daniel Bygrave's inventive contributions demonstrate his dedication to advancing biotechnological research. With his patent on polynucleotide synthesis and his work at Evonetix Limited, he is playing a vital role in shaping the future of genetic engineering. His collaboration with esteemed colleagues further enriches the innovative landscape in which he operates, making him a notable figure in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…